Just the FAQs: Frequently asked questions about iron and anemia in patients with chronic kidney disease

This publication has 21 references indexed in Scilit:

• Efficacy and Safety of Iron Sucrose for Iron Deficiency in Patients With Dialysis-Associated Anemia: North American Clinical Trial
  American Journal of Kidney Diseases, 2001
• Factors determining the percentage of hypochromic red blood cells in hemodialysis patients
  Kidney International, 1999
• A study of parenteral iron regimens in hemodialysis patients
  American Journal of Kidney Diseases, 1999
• Erythropoietin and iron use in peritoneal dialysis patients: Report from the 1997 HCFA end-stage renal disease core indicators project
  American Journal of Kidney Diseases, 1999
• Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia
  Kidney International, 1999
• Role of cytokines in the response to erythropoietin in hemodialysis patients
  Kidney International, 1998
• Randomized cross-over study of adverse reactions and cost implications of intravenous push compared with infusion of iron dextran in hemodialysis patients
  American Journal of Kidney Diseases, 1996
• The safety of intravenous iron dextran in hemodialysis patients
  American Journal of Kidney Diseases, 1996
• Iron and Infection
  The Journal of Trauma: Injury, Infection, and Critical Care, 1996
• Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era
  American Journal of Kidney Diseases, 1995